Sandra L Jackson1,2, Mary E Cogswell2, Lixia Zhao2,3, Ana L Terry4, Chia-Yih Wang4, Jacqueline Wright5, Sallyann M Coleman King2, Barbara Bowman, Te-Ching Chen4, Robert Merritt2, Catherine M Loria5. 1. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA (S.L.J.) SLJackson@cdc.gov. 2. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Chamblee, GA (S.L.J., M.E.C., L.Z., S.M.C.K., R.M.). 3. IHRC, Inc., Atlanta, GA (L.Z.). 4. National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD (A.L.T., C.-Y.W., T.-C.C.). 5. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (J.W., C.M.L.).
Abstract
BACKGROUND: Higher levels of sodium and lower levels of potassium intake are associated with higher blood pressure. However, the shape and magnitude of these associations can vary by study participant characteristics or intake assessment method. Twenty-four-hour urinary excretion of sodium and potassium are unaffected by recall errors and represent all sources of intake, and were collected for the first time in a nationally representative US survey. Our objective was to assess the associations of blood pressure and hypertension with 24-hour urinary excretion of sodium and potassium among US adults. METHODS: Cross-sectional data were obtained from 766 participants age 20 to 69 years with complete blood pressure and 24-hour urine collections in the 2014 National Health and Nutrition Examination Survey, a nationally representative survey of the US noninstitutionalized population. Usual 24-hour urinary electrolyte excretion (sodium, potassium, and their ratio) was estimated from ≤2 collections on nonconsecutive days, adjusting for day-to-day variability in excretion. Outcomes included systolic and diastolic blood pressure from the average of 3 measures and hypertension status, based on average blood pressure ≥140/90 and antihypertensive medication use. RESULTS: After multivariable adjustment, each 1000-mg difference in usual 24-hour sodium excretion was directly associated with systolic (4.58 mm Hg; 95% confidence interval [CI], 2.64-6.51) and diastolic (2.25 mm Hg; 95% CI, 0.83-3.67) blood pressures. Each 1000-mg difference in potassium excretion was inversely associated with systolic blood pressure (-3.72 mm Hg; 95% CI, -6.01 to -1.42). Each 0.5 U difference in sodium-to-potassium ratio was directly associated with systolic blood pressure (1.72 mm Hg; 95% CI, 0.76-2.68). Hypertension was linearly associated with progressively higher sodium and lower potassium excretion; in comparison with the lowest quartile of excretion, the adjusted odds of hypertension for the highest quartile was 4.22 (95% CI, 1.36-13.15) for sodium, and 0.38 (95% CI, 0.17-0.87) for potassium (P<0.01 for trends). CONCLUSIONS: These cross-sectional results show a strong dose-response association between urinary sodium excretion and blood pressure, and an inverse association between urinary potassium excretion and blood pressure, in a nationally representative sample of US adults.
BACKGROUND: Higher levels of sodium and lower levels of potassium intake are associated with higher blood pressure. However, the shape and magnitude of these associations can vary by study participant characteristics or intake assessment method. Twenty-four-hour urinary excretion of sodium and potassium are unaffected by recall errors and represent all sources of intake, and were collected for the first time in a nationally representative US survey. Our objective was to assess the associations of blood pressure and hypertension with 24-hour urinary excretion of sodium and potassium among US adults. METHODS: Cross-sectional data were obtained from 766 participants age 20 to 69 years with complete blood pressure and 24-hour urine collections in the 2014 National Health and Nutrition Examination Survey, a nationally representative survey of the US noninstitutionalized population. Usual 24-hour urinary electrolyte excretion (sodium, potassium, and their ratio) was estimated from ≤2 collections on nonconsecutive days, adjusting for day-to-day variability in excretion. Outcomes included systolic and diastolic blood pressure from the average of 3 measures and hypertension status, based on average blood pressure ≥140/90 and antihypertensive medication use. RESULTS: After multivariable adjustment, each 1000-mg difference in usual 24-hour sodium excretion was directly associated with systolic (4.58 mm Hg; 95% confidence interval [CI], 2.64-6.51) and diastolic (2.25 mm Hg; 95% CI, 0.83-3.67) blood pressures. Each 1000-mg difference in potassium excretion was inversely associated with systolic blood pressure (-3.72 mm Hg; 95% CI, -6.01 to -1.42). Each 0.5 U difference in sodium-to-potassium ratio was directly associated with systolic blood pressure (1.72 mm Hg; 95% CI, 0.76-2.68). Hypertension was linearly associated with progressively higher sodium and lower potassium excretion; in comparison with the lowest quartile of excretion, the adjusted odds of hypertension for the highest quartile was 4.22 (95% CI, 1.36-13.15) for sodium, and 0.38 (95% CI, 0.17-0.87) for potassium (P<0.01 for trends). CONCLUSIONS: These cross-sectional results show a strong dose-response association between urinary sodium excretion and blood pressure, and an inverse association between urinary potassium excretion and blood pressure, in a nationally representative sample of US adults.
Authors: Kevin W Dodd; Patricia M Guenther; Laurence S Freedman; Amy F Subar; Victor Kipnis; Douglas Midthune; Janet A Tooze; Susan M Krebs-Smith Journal: J Am Diet Assoc Date: 2006-10
Authors: Qi Sun; Kimberly A Bertrand; Adrian A Franke; Bernard Rosner; Gary C Curhan; Walter C Willett Journal: Am J Clin Nutr Date: 2016-11-09 Impact factor: 7.045
Authors: Mary E Cogswell; Joyce Maalouf; Paul Elliott; Catherine M Loria; Sheena Patel; Barbara A Bowman Journal: Annu Rev Nutr Date: 2015-05-06 Impact factor: 11.848
Authors: Lixia Zhao; Mary E Cogswell; Quanhe Yang; Zefeng Zhang; Stephen Onufrak; Sandra L Jackson; Te-Ching Chen; Catherine M Loria; Chia-Yih Wang; Jacqueline D Wright; Ana L Terry; Robert Merritt; Cynthia L Ogden Journal: Am J Clin Nutr Date: 2019-01-01 Impact factor: 7.045
Authors: Puthiery Va; Kevin W Dodd; Lixia Zhao; Angela M Thompson-Paul; Carla I Mercado; Ana L Terry; Sandra L Jackson; Chia-Yih Wang; Catherine M Loria; Alanna J Moshfegh; Donna G Rhodes; Mary E Cogswell Journal: Am J Clin Nutr Date: 2019-06-01 Impact factor: 7.045
Authors: Mary E Cogswell; Catherine M Loria; Ana L Terry; Lixia Zhao; Chia-Yih Wang; Te-Ching Chen; Jacqueline D Wright; Christine M Pfeiffer; Robert Merritt; Claudia S Moy; Lawrence J Appel Journal: JAMA Date: 2018-03-27 Impact factor: 56.272
Authors: Katherine J Overwyk; Zerleen S Quader; Joyce Maalouf; Marlana Bates; Jacqui Webster; Mary G George; Robert K Merritt; Mary E Cogswell Journal: Adv Nutr Date: 2020-09-01 Impact factor: 8.701
Authors: Cary R Boyd-Shiwarski; Claire J Weaver; Rebecca T Beacham; Daniel J Shiwarski; Kelly A Connolly; Lubika J Nkashama; Stephanie M Mutchler; Shawn E Griffiths; Sophia A Knoell; Romano S Sebastiani; Evan C Ray; Allison L Marciszyn; Arohan R Subramanya Journal: Am J Physiol Renal Physiol Date: 2020-04-13
Authors: Michelle M Averill; Rebekah L Young; Alexis C Wood; Emily O Kurlak; Holly Kramer; Lyn Steffen; Robyn L McClelland; Joseph A Delaney; Adam Drewnowski Journal: Stroke Date: 2019-02 Impact factor: 7.914
Authors: Martin Gritter; Liffert Vogt; Stanley M H Yeung; Rosa D Wouda; Christian R B Ramakers; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn Journal: Nephron Date: 2018-06-29 Impact factor: 2.847